Evidence map›Paper›PMID 41618502›Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Mathematical Modeling of the Role of Cytokines in Sindbis Virus Treatment of Glioblastoma.

Shriya Makam, Hana M Dobrovolny

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shriya MakamDepartment of Physics & Astronomy, Texas Christian University, Fort Worth, Texas, USA.
Hana M DobrovolnyDepartment of Physics & Astronomy, Texas Christian University, Fort Worth, Texas, USA.ORCID https://orcid.org/0000-0003-3592-6770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oncolytic viruses, specifically Sindbis virus (SINV), combined with cytokines show promising results in slowing glioma progression, but a quantitative understanding of their effects remains limited. In this study, we use an ordinary differential equation (ODE) model to examine the effect of adding cytokines to oncolytic SINV therapy. We fit the mathematical model to data extracted from published tumor growth curves to estimate key model parameters. We find that there are statistically significant differences between the infection rates of SINV and cytokine-bearing SINV, as well as differences in the cytokine's ability to reduce viral production. Model simulations show that the addition of cytokines causes an almost immediate reduction in the tumor size caused by the increased viral infection rate. The simultaneous reduction in viral production caused by the cytokines results in oscillations in virus, cytokines, and tumor volume. By providing parameter estimates for key biological processes, our model can help optimize treatment strategies and guide future research in oncolytic virotherapy.

Indexed as

Brain NeoplasmsCytokinesGlioblastomaModels, TheoreticalOncolytic VirotherapySindbis VirusAnimalsCell Line, TumorComputer SimulationHumansModels, BiologicalOncolytic VirusesCytokinescytokinesglioblastomagranulocyte macrophage‐colony stimulating factorinterleukinmathematical modelingoncolytic virus

Identifiers

PMID41618502
PMCPMC12896380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.